OBSOLETE: Herpes simplex virus keratitis Advocacy Hub | UniteRare

At a Glance

Live from database

💊

2FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for OBSOLETE: Herpes simplex virus keratitis.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Avaclyr

Fera Pharmaceuticals

OpenContact for details

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Avaclyr

(acyclovir)Orphan drugstandard

Fera Pharmaceuticals

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]

12.1 Mechanism of Action Acyclovir is an antiviral drug [see Microbiology ( 12.4 )] .

FDA label ↗

Zirgan

(ganciclovir)Orphan drugstandard

Sirion Therapeutics, Inc.

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]

12.1 Mechanism of Action ZIRGAN is an antiviral drug [ see Microbiology (12.4) ] .

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for OBSOLETE: Herpes simplex virus keratitis.
Search all trials →

Search clinical trials for OBSOLETE: Herpes simplex virus keratitis →

Recent News & Research

No recent news articles indexed yet for OBSOLETE: Herpes simplex virus keratitis.
Search PubMed for OBSOLETE: Herpes simplex virus keratitis →

Browse all OBSOLETE: Herpes simplex virus keratitis news →

Specialist Network

No specialists currently listed for OBSOLETE: Herpes simplex virus keratitis.

View all OBSOLETE: Herpes simplex virus keratitis specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰